Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: A prospective study using office endometrial biopsy

Journal of Clinical Oncology

Volumn 18, Issue 20, 2000, Pages 3459-3463

  Barakat, R R ^a   Gilewski, T A ^a   Almadrones, L ^a   Saigo, P E ^a   Venkatraman, E ^a   Hudis, C ^a   Hoskins, W J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG SURVEILLANCE PROGRAM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034668074     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.20.3459     Document Type: Article

References (28)

1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 Randomized clinical trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
2. Recent advances in understanding the molecular mechanisms of tamoxifen action
3. Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens
4. Tamoxifen as risk factor for carcinoma of corpus uteri
5. Tamoxifen and the uterus and endometrium
6. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
7. Four case reports presenting new acquisitions on the association of breast and endometrial cancer
8. Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy
9. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients
10. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients
11. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen
12. Gynecologic tumors in tamoxifen-treated women with breast cancer
13. Risk of endometrial cancer after tamoxifen treatment of breast cancer
14. Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features
15. Gynecologic effects of tamoxifen and the association with endometrial carcinoma
16. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
17. Tamoxifen therapy for breast cancer and endometrial cancer risk
18. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
19. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
20. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen
21. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening
22. Oncologic potential of tamoxifen on endometria of postmenopausal women with breast cancer: Preliminary report
23. Endometrial pathology at dilation and curettage in breast cancer patients: Comparison of tamoxifen users and nonusers
24. The behavior of endometrial hyperplasia: A study of untreated endometrial hyperplasia in 170 women
25. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients
26. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: The effects of tamoxifen
27. The effect of tamoxifen on the endometrium
28. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer